Literature DB >> 34184365

MRI-Based Investigation of Association Between Cerebrovascular Structural Alteration and White Matter Hyperintensity Induced by High Blood Pressure.

Boyu Zhang1,2, Yingzhe Wang3,4, Bei Wang1,2, Ying-Hua Chu5, Yanfeng Jiang3,4, Mei Cui6, He Wang1,2,7, Xingdong Chen3,4.   

Abstract

BACKGROUND: High blood pressure (BP) is a common risk factor for cerebral small vessel disease including white matter hyperintensity (WMH). Whether increased BP exacerbates WMH by impacting cerebral vascular morphologies remains poorly studied.
PURPOSE: To determine the relationships among high BP, cerebrovascular morphologies, and WMH in elderly individuals. STUDY TYPE: Cohort.
SUBJECTS: Eight hundred sixty-three participants (54.2% female) from the Taizhou Imaging Study without clinical evidence of neurologic disorders were included in the analyses. FIELD STRENGTH/SEQUENCE: 3.0 T; time-of-flight magnetic resonance angiography (TOF MRA); T2 fluid-attenuated inversion recovery (FLAIR); T1 magnetization-prepared rapid gradient-echo; gradient echo T2*-weighted; diffusion tensor imaging; pulsed arterial spin labeling. ASSESSMENT: Cerebrovascular morphologic measurements were quantified based on the TOF MRA images, including vessel density, radius, tortuosity, and branch number. WMH lesion volumes (WMHV) and WMH lesion counts (WMHC) were calculated automatically based on the T2 FLAIR images. STATISTICAL TESTS: Multivariable linear regression analysis and path analysis with a linear single-mediator model were employed. A P value <0.05 was considered statistically significant.
RESULTS: Higher BP, especially diastolic BP, was significantly correlated with lower cerebrovascular density (β = -104) and lower branch numbers (β = -0.02). Although decreased tortuosity (β = -1.25) and increased radius (β = 93.8) were correlated with BP, no significant relationship of tortuosity (β = -4.6 × 10-4 , P = 0.58) or radius (β = 0.03, P = 0.08) with BP in small vessels was found. The proportion of small vessels decreased as BP increased (SBP: β = -6.6 × 10-4 ; DBP: β = -9.0 × 10-4 ). Similarly, increased WMHV and WMHC were associated with decreased vessel density (volumes: β = -24, counts: β = -127), decreased tortuosity (volumes: β = -0.08, counts: β = -0.53), and increased radius (volumes: β = 12.6, counts: β = 86.6). Path analyses suggested an association between high BP and WMHs that were mediated by cerebrovascular morphologic changes. DATA
CONCLUSION: Structural alterations of cerebral vessels induced by high BP are correlated with WMH. This result suggested that elevated BP might be one of the pathophysiological mechanisms involving in the co-occurrence of cerebrovascular alteration and small vessel disease. LEVEL OF EVIDENCE: 1 Technical Efficacy Stage: 1.
© 2021 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  hypertension; magnetic resonance angiography; vascular disease; vascular imaging; white matter disease

Year:  2021        PMID: 34184365     DOI: 10.1002/jmri.27815

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  3 in total

1.  Modification of cerebrovascular morphologies during different stages of life.

Authors:  Boyu Zhang; Zidong Yang; Jing Li; Bei Wang; Huazheng Shi; He Wang; Yuehua Li
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-01       Impact factor: 6.960

2.  Editorial for "MRI-Based Investigation of Association Between Cerebrovascular Structural Alteration and White Matter Hyperintensity Induced by High Blood Pressure".

Authors:  Mikko T Huuskonen; Giuseppe Barisano; Ararat Chakhoyan; Berislav V Zlokovic
Journal:  J Magn Reson Imaging       Date:  2021-07-31       Impact factor: 4.813

3.  Day to Day Blood Pressure Variability Associated With Cerebral Arterial Dilation and White Matter Hyperintensity.

Authors:  Boyu Zhang; Yajing Huo; Zidong Yang; Huihui Lv; Yilin Wang; Jianfeng Feng; Yan Han; He Wang
Journal:  Hypertension       Date:  2022-05-03       Impact factor: 9.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.